Literature DB >> 17063773

Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.

Gloria Luz Paniagua1, Eric Monroy, Erasmo Negrete, Sergio Vaca.   

Abstract

Eighty Candida albicans strains, isolated from throat of patients at the Universitary Clinic of the Faculty of Superior Studies Iztacala of the National Autonomous University of Mexico, were analyzed. They were identified by microscopic and colony morphologies, germ tube test, and by auxanogram and zimogram. Minimal inhibitory concentrations (MIC) of 5-fluorocytosine, miconazole and amphotericin B were determined by microtiter broth dilution. MIC frequency distribution of 5-fluorocytosine showed a single peak (0.25-8.0 microg/ml), with 65% susceptible strains (MIC < or = 1.0 < or =g/ml) and 35% intermediate susceptible strains (MIC = 1.1-8 microg/ml). MIC frequency distribution of miconazole was threemodal with 6.25% susceptible (MIC = 1.562 microg/ml), 48.75% intermediate susceptible (MIC = 3.125-12.5 microg/ml), and 45% resistant (MIC = 25-50 microg/ml) strains. All strains were susceptible to amphotericin B (MIC= 0.0156-0.125 microg/m). These results shows that amphotericin B was the more active antimycotic, followed by 5-fluorocytosine, against the strains analyzed, and that miconazole was the less effective one.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 17063773

Source DB:  PubMed          Journal:  Rev Latinoam Microbiol        ISSN: 0187-4640


  4 in total

1.  Susceptibilities of Candida albicans mouth isolates to antifungal agents, essentials oils and mouth rinses.

Authors:  Sara Carvalhinho; Ana Margarida Costa; Ana Cláudia Coelho; Eugénio Martins; Ana Sampaio
Journal:  Mycopathologia       Date:  2012-01-14       Impact factor: 2.574

2.  Management of oropharyngeal candidiasis with localized oral miconazole therapy: efficacy, safety, and patient acceptability.

Authors:  Curtis D Collins; Sarah Cookinham; Jeannina Smith
Journal:  Patient Prefer Adherence       Date:  2011-07-19       Impact factor: 2.711

3.  Sensitivity of clinical isolates of Candida to essential oils from Burseraceae family.

Authors:  Miloš Nikolic; Marija Smiljkovic; Tatjana Markovic; Ana Cirica; Jasmina Glamoclija; Dejan Markovic; Marina Sokovic
Journal:  EXCLI J       Date:  2016-04-19       Impact factor: 4.068

4.  Miconazole-Urea in a Buccal Film as a New Trend for Treatment of Resistant Mouth Fungal White Patches.

Authors:  Omar Y Mady; Ahmed M Donia; Lamiaa A Al-Madboly
Journal:  Front Microbiol       Date:  2018-05-11       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.